Insitrex-TZ 1.125 Injection
Marketer
Insinius Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Insitrex-TZ 1.125 Injection
Insitrex-TZ 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical practitioner. Consistent adherence to the prescribed schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise treatment efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Prior to commencing treatment, disclose all current medications to your physician. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, avoid driving if experiencing somnolence or vertigo. Sufficient rest, nutritious food, and ample hydration are recommended for optimal recovery. Monitoring treatment efficacy may involve periodic lab tests and diagnostic assessments as directed by your physician.
Uses of Insitrex-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Insitrex-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Insitrex-TZ 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Insitrex-TZ 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Insitrex-TZ 1.125 Injection works:
Insitrex-TZ 1.125 Injection unites Ceftriaxone, a bacterial cell wall synthesis inhibitor, with Tazobactum, a beta-lactamase inhibitor. This dual-action formulation combats bacterial infection by disrupting bacterial cell wall formation (Ceftriaxone) and counteracting bacterial defenses that would otherwise inactivate the antibiotic (Tazobactum).
SAFETY ADVICE
AlcoholSAFE
Insitrex-TZ 1.125 Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Insitrex-TZ 1.125 Injection is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Insitrex-TZ 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Insitrex-TZ 1.125 Injection can cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Insitrex-TZ 1.125 Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Insitrex-TZ 1.125 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Insitrex-TZ 1.125 Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Insitrex-TZ 1.125 Injection :
Should you forget a scheduled Insitrex-TZ 1.125 Injection, seek medical advice.
Facts to Know About Insitrex-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently